Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511453
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
Acupressure in Patients With Sickle Cell Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease SCD
Detailed Description:
This study will help the investigators learn whether acupressure a non-pharmacological alternative treatment approach can help manage pain in patients with sickle cell disease Acupressure involves the application of pressure stimulation at specific acupoints on the body Acupressure may help relieve pain and is used for a wide variety of pain conditions Participation in this study will consist of remote self-administered treatment every other day over 5 weeks followed by 6 months of remote follow-up visits During participation subjects will 1 receive detailed instruction on locating treatment acupoints and completing study procedures remotely 2 be assigned a treatment kit 3 answer questions about their personal and health-related information for assessing their health condition before during and after the treatment during follow-up sessions and 4 collect inner eyelid images for examining the hemoglobin level on a weekly basis at steady phase and daily basis during acute vaso-occlusive crisis stage
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None